Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. (SNDX) — Form 3: Initial insider holdings
About this filing
Syndax Pharmaceuticals, Inc. (SNDX) filed Form 3 (initial insider holdings) with the SEC on Nov 12, 2026.
Key facts
Key facts aren’t available for this filing right now. The original on SEC.gov has the full filing.
More SNDX filings
- 4
Filed Nov 12, 2026
- 10-Q
Filed Nov 2, 2026
- 8-K
Filed Nov 2, 2026
- 4
Filed Oct 30, 2026
- 144
Filed Oct 29, 2026
- SC 13G
Filed Aug 7, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.